Intramuscular testosterone undecanoate is available in the United States , Canada , Europe , and elsewhere in the world.    It is approved in over 100 countries worldwide.   Oral testosterone undecanoate is available in Canada, Europe, Mexico, Asia, and elsewhere but not in the United States.   Intramuscular testosterone undecanoate is marketed most commonly as Nebido in Canada and Europe and as Aveed in the United States while oral testosterone undecanoate is marketed most commonly as Andriol.   
There are possible side effects of Testosterone Enanthate use, but we will find they are extremely easy to avoid for the healthy adult male. When we refer to the healthy adult male we are excluding the issue of low testosterone. For the low level patient, the probability of side effects will be extremely low. In such a case, the individual is merely replacing what he’s lacking and nothing more. For the performance athlete, the side effects of Testosterone Enanthate will carry a greater probability, but should still be very controllable. Most men can tolerate high levels of testosterone very well. However, as with many things in life individual response and sensitivity issues will play a role. This is not unique to Testosterone Enanthate but holds true with all things we put in our body. In order to understand the possible side effects of Testosterone Enanthate, we have broken them down into their separate categories along with all the information you’ll need.
The US FDA requires a Risk Evaluation and Mitigation Strategy (REMS) medication guide for Testosterone. For Testosterone Undecanoate, REMS includes elements to assure safe use and implementation system . For additional information: /REMS
US BOXED WARNINGS :
Pulmonary Oil Microembolism (POME) Reactions And Anaphylaxis :
-Serious POME reactions, involving urge to cough, dyspnea, throat tightening, chest pain, dizziness, and syncope; and episodes of anaphylaxis, including life-threatening reactions, have been reported to occur during or immediately after the administration of testosterone undecanoate injection. These reactions can occur after any injection of testosterone undecanoate during the course of therapy, including after the first dose.
-Following each injection of testosterone undecanoate observe patients in the healthcare setting for 30 minutes in order to provide appropriate medical treatment in the event of serious POME reactions or anaphylaxis.
Secondary Exposure To Topical Testosterone :
-Virilization has been reported in children who were secondarily exposed to topical testosterone products.
-Children should avoid contact with unwashed or unclothed application sites in men using testosterone topical.
-Healthcare providers should advise patients to strictly adhere to recommended instructions for use.
Safety and efficacy have not been established in patients younger than 18 years.
Testosterone Enanthate and Testosterone Implant are indicated for delayed puberty in adolescent patients.
Testosterone Cypionate: Safety and efficacy have not been established in patients younger than 12 years.
Consult WARNINGS section for additional precautions.